I notice a bit of news recently from the European Alliance for Access to Safe Medicines (EAASM). It seems that the EAASM reckons the parallel trade in drugs in the EU puts patients at risk… but there is world of difference between the legal parallel trade and drug counterfeiting. But not as far as my old mate Jim Thomson is concerned and the EAASM is Jim’s latest drug company funded venture. The cynical amongst you might think that Jim and the EAASM only link the parallel trade with counterf

More: continued here